Oncology Archives - Page 16 of 22

A QTWiST Analysis of Glasdegib Plus Low‐Dose Cytarabine Versus Low‐Dose Cytarabine as Initial Therapy for Acute Myeloid Leukemia in Patients Who Are Not Considered Candidates for Intensive Chemotherapy

Authors: CT Solem, TJ Bell, Y Kwon, JC Cappelleri, C Johnson, H Bhattacharyya, CJ Hoang, JE Cortes Published: Cancer, 2020 View publication A Quality‐Adjusted Survival Time Without Symptoms or Toxicities Analysis of...

Epidemiologic, humanistic and economic burden of hepatocellular carcinoma in the USA: a systematic literature review

Authors: A Aly, S Ronnebaum, D Patel, Y Doleh, F Benavente Published: Future Medicine, 2020 View publication Materials & Methods Studies describing the epidemiology and economic burden from national cohorts, any economic...

Physician preferences for non-metastatic castration-resistant prostate cancer treatment

Authors: S Srinivas, A F Mohamed, S Appukkuttan, M Botteman, X Ng, N Joshi, E Horodniceau, A R Waldeck, S J Simmons Published: BMC Urology, 2020 View publication Background Recent approvals of...

Nomogram for estimating overall survival in patients with metastatic pancreatic cancer

Authors: D Goldstein, D D Von Hoff, E G Chiorean, M Reni, J Tabernero, R K Ramanathan, M Botteman, A Aly, S Margunato-Debay, B Lu, CU Louis, D McGovern, C Khoon Lee...

The Costs of Treating Vaginal and Vulval Cancer in England (2009–2015)

Authors: S Stephens, A Chatterjee, V Coles, R Crawford Published: BMC Public Health, 2020 View publication Background Human papillomavirus (HPV) infection is a pre-requisite for cervical cancer, which represents the third most...

Landscape of health-related quality of life in patients with early-stage pancreatic cancer receiving adjuvant or neoadjuvant chemotherapy: a systematic literature review

Authors: T Macarulla, A Hendifar, L Chung-Pin, M Reni, H Riess, M A Tempero, A C Dueck, M F Botteman, C G Deshpande, E J Lucas, D Oh Published: Pancreas, 2020 View...

Management of patients with acute lymphoblastic leukemia in routine clinical practice: Minimal residual disease testing, treatment patterns and clinical outcomes in Belgium, Greece and Switzerland

Authors: D Deeren, S Balabanov, K Nickel, C Giannopoulou, S Gonzalez-McQuire, L Kutikova, W Bouwmeester, A Spyridonidis Published: Leukemia Research, 2020 View publication Objectives To describe real-world management and clinical and economic...

Costs and cost drivers associated with non-small-cell lung cancer patients who received two or more lines of therapy in Europe

Authors: K Verleger, J R Penrod, M M Daumont, C Solem, L Luo, C Macahilig, N Hertel Published: ClinicoEcnommics and Outcomes Research, 2020 View publication Purpose Advanced non-small-cell lung cancer (aNSCLC; stage...

Development of an initial conceptual model of multiple myeloma to support clinical and health economics decision making

Authors: S Gonzalez-McQuire, M A Dimopoulos, K Weisel, W Bouwmeester, R Hajek, M Campioni, C Bennison, W Xu, K Pantiri, M Hensen, E Terpos, S Knop Published: MDM Policy & Practice, 2019...

News